CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
CPXX
Delisted
CPXX was delisted on the 11th of July, 2016.
7 hedge funds and large institutions have $10.8M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2014 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$614K |
| 2 |
OM
2
Opaleye Management
Boston,
Massachusetts
|
$1.03M |
| 3 |
CPA
3
Cowen Prime Advisors
New York
|
$40K |
| 4 |
U
4
UBS
Zurich,
Switzerland
|
$10K |
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$2.02M |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$0 |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CC
1
Caxton Corporation
Princeton,
New Jersey
| $7.12M | 2,246,469 | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $2.02M | 626,077 | -53,515 | -8% |
|
|
OM
3
Opaleye Management
Boston,
Massachusetts
| $1.03M | 325,000 | +15,000 | +5% |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $614K | 189,967 | +189,967 | New |
|
|
CPA
5
Cowen Prime Advisors
New York
| $40K | 12,750 | +12,750 | New |
|
|
U
6
UBS
Zurich,
Switzerland
| $10K | 3,045 | +2,885 | +1,803% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | – | -540 | Closed |
|
|
8
Bank of America
Charlotte,
North Carolina
| – | – | -467 | Closed |
|
9
Morgan Stanley
New York
| $0 | 44 | +44 | New |
|